References
- Acikgoz M, Kas HS, Hascelik Z, Milli U, Hincal AA. Chitosan microspheres of diclofenac sodium, II: In vitro and in vivo evaluation. Pharmazie 1995; 50: 275–277
- Babay D, Hoffman A, Benita S. Design and release kinetic pattern evaluation of indomethasin microspheres intended for oral administration. Biomaterials 1998; 9: 428–488
- Cortesi R, Esposito E, Gambarin S, Telloli P, Menegatti E, Nastruzzi C. Preparation of liposomes by reverse-phase evaporation using alternative organic solvents. J Microencapsulation 1999; 16: 251–256
- Davis SS. The design and evaluation of controlled release system for the gastrointestinal tract. J Contr Rel 1985; 2: 27–38
- Desai S, Bolton S. A floating controlled-release drug delivery system: In vitro–in vivo evaluation. Pharm Res 1993; 10: 1321–1325
- Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence; an overview. Drug Dev Ind Pharm 1996; 22: 531–539
- Fulzele SV, Satturwar PM, Kasliwal RH, Dorle AK. Preparation and evaluation of microcapsules using polymerized rosin as novel wall forming material. J Microencapsulation 2004; 21: 83–89
- Iannuccelli V, Coppi G, Bernabei MT, Cameroni R. Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int J Pharm 1998; 174: 47–54
- Jenning V, Thunemann AF, Gohla SH. Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 2000; 199: 167–177
- Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 1992; 81: 135–140
- Martin L, Wilson CG, Koosha F, Tetley L, Gray AI, Senel S, et al. The release of model macromolecules may be controlled by the hydrophobicity of palmitoylglycol chitosan hydrogels. J Contr Rel 2002; 80: 87–100
- Miyagawa Y, Okabe T, Yamaguchi Y, Miyajima M, Sato H, Sunada H. Controlled-release of diclofenac sodium from wax matrix granule. Int J Pharm 1996; 138: 215–224
- Oth M, Franz M, Timmermans J, Moës A. The bilayer floating capsule: A stomach-dried drug delivery system for misoprostol. Pharm Res 1992; 9: 298–302
- Pandit SS, Hase DP, Bankar MM, Patil AT, Gaikwad NJ. Ketoprofen-loaded Eudragit RSPO microspheres: An influence of sodium carbonate on in vitro drug release and surface topology. J Microencapsulation 2008; i-first: 1–7
- Porter SC, Ghebre-Sellassie I. Key factors in the development of modified-release pellets. Multiparticulate oral drug delivery, I Ghebre-Sellassie. Marcel Dekker, New York 1994; 217–284
- Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J Microencapsulation 1999; 16: 205–213
- Tandt LAGL, Stubbs C, Kanfer I. The use of dissolution rate to account for differences in the absorption profiles of two controlled/modified-release capsule dosage forms of indomethasin in human volunteers. Int J Pharm 1994; 104: 11–17
- Testa R, Leonardi A, Tajana A, Riscassi E, Magliocca R, Sartani A. Lercanidipine (Rec 15/2375): A novel 1,4-dihydropyridine calcium antagonist for hypertension. Cardiovasc Drug Rev 1997; 15: 187–219
- Vyas SP, Singh R, Dimitrijevic D. Development and characterization of nifedipine lipospheres. Pharmazie 1997; 52: 403–404
- Whitehead L, Fell JT, Collett JH, Sharma HL, Smith AM. An in vivo study demonstrating prolonged gastric retention. J Contr Rel 1998; 55: 3–12